Fund shareholders of Verrica Pharmaceuticals Inc
ISIN US92511W2070 · United States · LEI 5493002L68H6THU5GW50
- Fund shareholders
- 13
- Of which ETFs
- 3 10 other funds
- Value held
- 1.4M $
- Share of capital
- 1.5 % of 17.2M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 135,937 | 719.1K $ | 0.00 % | 0.79 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 52,821 | 279.4K $ | 0.31 % | as of Mar 31, 2026 ↗ | |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 28,182 | 154.2K $ | 0.00 % | 0.16 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 11,139 | 60.9K $ | 0.06 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 9,479 | 51.9K $ | 0.00 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 9,107 | 49.8K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 7,373 | 47K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 1,607 | 8.5K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 800 | 5.1K $ | 0.00 % | as of Apr 30, 2026 ↗ | |
| Avantis Total Equity Markets ETF American Century ETF Trust | 481 | 2.6K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 198 | 1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 90 | 476.1 $ | 0.00 % | as of Mar 31, 2026 ↗ | |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 42 | 265 $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Small Cap Core Fund Northern Funds | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 0.00 % | as of Apr 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 13 | +2 | 257,256 | +43.2 % |
| 2026Q1 | 11 | +1 | 179,599 | -33.4 % |
| 2025Q4 | 10 | +9 | 269,767 | +1,193,557.5 % |
| 2025Q3 | 1 | 23 |
Institutional managers
36 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Caligan Partners LP | 923,910 | 4.9M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 707,338 | 3.7M $ | as of Mar 31, 2026 |
| CANNELL CAPITAL LLC | 685,123 | 3.6M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 518,181 | 2.7M $ | as of Mar 31, 2026 |
| Velan Capital Investment Management LP | 471,559 | 2.5M $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 280,734 | 1.5M $ | as of Mar 31, 2026 |
| DAFNA Capital Management LLC | 153,712 | 813.1K $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 140,497 | 743.2K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 138,917 | 735K $ | as of Mar 31, 2026 |
| Stonepine Capital Management, LLC | 99,735 | 527.6K $ | as of Mar 31, 2026 |
| Squarepoint Ops LLC | 75,208 | 397.9K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 50,662 | 268K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 49,211 | 260.3K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 38,553 | 203.9K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 32,360 | 171.2K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 31,580 | 167.1K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 28,916 | 153K $ | as of Mar 31, 2026 |
| Mariner, LLC | 24,544 | 129.8K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 22,386 | 118.4K $ | as of Mar 31, 2026 |
| Legacy Trust | 17,234 | 91.2K $ | as of Mar 31, 2026 |
| Verdad Advisers, LP | 12,098 | 64K $ | as of Mar 31, 2026 |
| BECK MACK & OLIVER LLC | 12,000 | 63.5K $ | as of Mar 31, 2026 |
| UBS Group AG | 4,270 | 22.6K $ | as of Mar 31, 2026 |
| Capital Analysts, LLC | 1,500 | 8 $ | as of Mar 31, 2026 |
| ROYAL BANK OF CANADA | 954 | 5K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of Verrica Pharmaceuticals Inc". https://titelia.com/en/stocks/verrica-pharmaceuticals-inc-US92511W2070